Diagnosis of sepsis, severe sepsis and septic shock;Diagnostic du sepsis, du sepsis severe et du choc septique

Presse Medicale

Volumn 33, Issue 4, 2004, Pages 262-264

  Bossi, Philippe ^a   Grimaldi, David ^a   Caille, Vincent ^b   Vieillard Baron, Antoine ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR;

BLOOD PRESSURE; CAUSE OF DEATH; CLINICAL FEATURE; DISEASE SEVERITY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEMODYNAMICS; HUMAN; HYPERTENSION; HYPOTENSION; IMMUNE DEFICIENCY; INCIDENCE; INFECTION; INTENSIVE CARE; MICROBIOLOGICAL EXAMINATION; MORTALITY; MULTIPLE ORGAN FAILURE; MYCOSIS; REVIEW; RISK FACTOR; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TISSUE PERFUSION; VIRULENCE;

EID: 1442340001     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(04)98552-1     Document Type: Article

References (12)

1. Bone RC, Balk RA, Cerra FB et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians Society of Critical Care Medicine. Chest. 1992; 101: 1644-55.
2. Wheeler AP, Bernard GR, Treating patients with severe sepsis. N Engl J Med 1999; 340: 207-14.
3. Increase in National Hospital Discharge Survey rates for septicemia-United States, 1979-1987. MMWR Morb Mortal Wkly Rep 1990; 39: 31-4
4. Martin G, Mannino D, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-54.
5. Rivers E, Nguyen B, Havstad S et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-77.
6. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B. Current epidemiology of septic shock. Am J Respir Crit Care Med 2003; 168: 165-72.
7. Angus D, Unde-Zwirble W, Lidicker J et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated cost of care. Crit Care Med 2001; 29: 1303-10.
8. Fisher CJ Jr, Agosti JM, Opal SM et al. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 1996; 334: 1697-702.
9. Bernard GR, Wheeler AP, Russell JA et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med 1997; 336: 912-18.
10. Sakkinen PA, Cushman M, Psaty BM et al. Correlates of antithrombin, protein C, protein S, and TFPI in a healthy elderly cohort. Thromb Haemost 1998; 80: 134-9.
11. Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz D. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000; 68: 6398-401.
12. Mita JP, Cariou A, Grall F et al. Association of TNF2, a TNF-α promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999; 282: 561-8.